EP0345260A1 - Procede de traitement des mammiferes utilisant des anticorps contre le facteur de grossesse precoce (epf) - Google Patents

Procede de traitement des mammiferes utilisant des anticorps contre le facteur de grossesse precoce (epf)

Info

Publication number
EP0345260A1
EP0345260A1 EP88900671A EP88900671A EP0345260A1 EP 0345260 A1 EP0345260 A1 EP 0345260A1 EP 88900671 A EP88900671 A EP 88900671A EP 88900671 A EP88900671 A EP 88900671A EP 0345260 A1 EP0345260 A1 EP 0345260A1
Authority
EP
European Patent Office
Prior art keywords
epf
antibody
antibodies
active fragment
polyclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP88900671A
Other languages
German (de)
English (en)
Other versions
EP0345260A4 (fr
Inventor
Halle Morton
Alice Christina Cavanagh
Barbara Ellen Rolfe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland UQ
Original Assignee
University of Queensland UQ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ filed Critical University of Queensland UQ
Publication of EP0345260A1 publication Critical patent/EP0345260A1/fr
Publication of EP0345260A4 publication Critical patent/EP0345260A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Abstract

Des anticorps monoclonaux et polyclonaux contre l'EPF et des fragments actifs desdits anticorps peuvent être utilisés pour identifier des cellules cancéreuses qui produisent l'EPF, afin d'assurer très tôt un contrôle du cancer chez les mammifères. On peut détruire les cellules cancéreuses chez le mammifère en lui administrant les anticorps de l'EPF ou des fragments desdits anticorps. Ceux-ci sont utiles pour détecter la présence de l'EPF dans le sérum durant la grossesse et pour servir à détecter un état de grossesse chez les mammifères et si nécessaire, à y mettre un terme.
EP19880900671 1986-12-22 1987-12-22 Procede de traitement des mammiferes utilisant des anticorps contre le facteur de grossesse precoce (epf). Withdrawn EP0345260A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH961286 1986-12-22
AU9612/86 1986-12-22

Publications (2)

Publication Number Publication Date
EP0345260A1 true EP0345260A1 (fr) 1989-12-13
EP0345260A4 EP0345260A4 (fr) 1990-05-14

Family

ID=3771965

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880900671 Withdrawn EP0345260A4 (fr) 1986-12-22 1987-12-22 Procede de traitement des mammiferes utilisant des anticorps contre le facteur de grossesse precoce (epf).

Country Status (3)

Country Link
EP (1) EP0345260A4 (fr)
JP (1) JPH02501160A (fr)
WO (1) WO1988004779A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU684577B2 (en) 1993-11-30 1997-12-18 University Of Queensland, The Chaperonin 10
CA2176948C (fr) * 1993-11-30 2007-05-15 Halle Morton Chaperonine 10
US7034120B2 (en) 1999-02-02 2006-04-25 Edp Biotech Corporation, Inc. Method and apparatus for detecting conception in animals
EP1053473A4 (fr) 1998-02-02 2003-08-13 Concepto Diagnostics Inc Procede et appareil de detection de la fecondation chez les animaux
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
AU3511900A (en) * 1999-03-02 2000-09-21 Kems Bio-Test Ltd. Bovine pregnancy testing
AU2012358146B2 (en) 2011-12-23 2015-09-17 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
CN108314732A (zh) * 2018-01-15 2018-07-24 妊达（北京）生物技术有限公司 一种抗牛早孕因子单克隆抗体细胞株单克隆抗体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005498A1 (fr) * 1985-03-12 1986-09-25 University Of Queensland Procede de detection de facteur de determination precoce de grossesse (epf) ches des mammiferes, procedes de purification d'epf et de production d'anticorps monoclonaux

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 105, no. 13, 29th September 1986, page 473, abstract no. 112770u, Columbus, Ohio, US; T.K. ROBERTS et al.: "Early pregnancy factor of human urine", & REPROD. PERINAT. MED. 1985, 1(EARLY PREGNANCY FACTORS), 191-3 *
See also references of WO8804779A1 *

Also Published As

Publication number Publication date
EP0345260A4 (fr) 1990-05-14
JPH02501160A (ja) 1990-04-19
WO1988004779A1 (fr) 1988-06-30

Similar Documents

Publication Publication Date Title
US6419928B1 (en) Monoclonal antibodies to transforming growth factor-beta and methods of use
Tomasi Jr Structure and function of mucosal antibodies
EP0764030B1 (fr) Composition contenant d'autoanticorps pour la therapie et la prophylaxie antitumorale
EP0117114B1 (fr) Anticorps monoclonal
PT94381B (pt) Processo para a preparacao de uma composicao contendo um imunogeno para tratamentos antialergicos
EP0345260A1 (fr) Procede de traitement des mammiferes utilisant des anticorps contre le facteur de grossesse precoce (epf)
RU2163243C2 (ru) Белки из печени козы, обладающие противоопухолевой активностью, фармацевтическая композиция
JPS60155133A (ja) アンチ−イデイオタイプのモノクロナル抗体を採用したアンチ−イデイオタイプワクチン
JPH05503098A (ja) セプシスの処理のためのサイトカイン抗体
US5330896A (en) Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells
AU603053B2 (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
EP0253646B1 (fr) Anticorps monoclonal anti-cancer gastrique humain
Rose et al. Studies on Organ Specificity: VI. Cross-Reactions of Thyroid Autoantibodies with Thyroids of Other Species
Orlans et al. Clostridium welchii: Epsilon-Toxin and Antitoxin
Gratecos et al. A new approach to monoclonal antibody production In vitro immunization with antigens on nitrocellulose using Drosphila myosin heavy chain as an example
Ferrone et al. A biologic and chemical profile of histocompatibility antigens
Chiu et al. Immunospecificity of nuclear nonhistone protein-DNA complexes in colon adenocarcinoma
JPH05506241A (ja) ３５ｋｄ腫瘍関連タンパク質抗原および免疫複合体
EP0331743B1 (fr) Proteine derivee d'un corps vivant
CN1166838A (zh) 同种异体和异基因蛋白的抗体，它们在诊断和治疗中的应用及其检测方法
EP0272113A2 (fr) Anticorps monoclonaux contre le cancer humain
Toben et al. Alteration of immunological reactivity in chickens by the in ovo administration of antisera against central lymphoid tissue
JPH03505575A (ja) 幹細胞阻害剤
落合謙爾 et al. Suppressive effect on tumor growth of enzootic bovine leukemia cells in nude mice by monoclonal antibodies against tumor-associated antigens.
GB2212502A (en) Monoclonal antibody and preparation and use thereof.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890621

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19900514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19910906